Clinical Trial: A single-arm, single-center, exploratory clinical study of Iparomlimab and Tuvonralimab in combination with S-1 as first-line treatment for elderly patients ( ＞=75 years) with esophageal squamous cell carcinoma (ESCC) (China)

China, Aug. 14 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A single-arm, single-center, exploratory clinical study of Iparomlimab and Tuvonralimab in combination with S-1 as first-line treatment for elderly patients ( ＞=75 years) with esophageal squamous cell carcinoma (ESCC)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130033

Registration Time: 2026/08/13

Type: Interventional study

Primary Sponsor: Sichuan Provincial People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335221

Published by HT Digital Content Services with permission from Health Daily Digest....